REPL CIK: 1737953

Replimune Group, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY23
FY24
FY25
FY26
FY22 – FY26
(positive)
Change from FY22 to FY26
millions USD
FY22:
−82.2
FY23:
−128
FY24:
−185
FY25:
−192
FY26:
−280
Change from FY22 to FY26
millions USD
FY22:
−1.81
FY23:
−143
FY24:
97.2
FY25:
−23.8
FY26:
311
Change from FY22 to FY26
millions USD
FY22:
6.60
FY23:
311
FY24:
16.3
FY25:
252
FY26:
66.3
millions USD
FY22:
−76.6
FY23:
40.6
FY24:
−72.1
FY25:
36.7
FY26:
97.9
(positive)
Change from FY22 to FY26
millions USD
FY22:
−84.5
FY23:
−130
FY24:
−191
FY25:
−199
FY26:
−285

All amounts in millions USD Data source:SEC EDGAR